Suchergebnisse - "Safra, Tamar"

PubPharm (105)

11

Impact of disease progression on health-related quality of life of advanced ovarian cancer patients - Pooled analysis from the PRIMA trial

enthalten in: Gynecologic oncology | 2022

von Chase, D. | Marín, M. | Backes, F. | +18

12

Brain metastases in patients with ovarian cancer

enthalten in: Acta oncologica (Stockholm, Sweden) | 2022

von Limon, D. | Shachar, E. | Wolf, I. | +4

13

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4) : an international, open-label, randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2022

von Kristeleit, R. | Lisyanskaya, A. | Fedenko, A. | +22

CommentIn: Lancet Oncol. 2022 Apr;23(4):440-441. - PMID 35298905

14

Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer : Results From the KEYNOTE-158 Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von O'Malley, D. | Bariani, G. | Cassier, P. | +11

15

A randomized, phase III trial to evaluate rucaparib monotherapy as maintenance treatment in patients with newly diagnosed ovarian cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45) : original reports

enthalten in: Journal of clinical oncology | June 6, 2022

von Monk, B. | Parkinson, C. | Lim, M. | +36

16

ATHENA (GOG-3020/ENGOT-ov45) : a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2021

von Monk, B. | Coleman, R. | Fujiwara, K. | +18

17

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

enthalten in: The New England journal of medicine | 2021

von Colombo, N. | Dubot, C. | Lorusso, D. | +117

CommentIn: Nat Rev Clin Oncol. 2021 Dec;18(12):747. - PMID 34616034

18

Concomitant diagnosis of endometrial and breast cancer - does the sequence matters?

enthalten in: Gynecologic oncology reports | 2021

von Stern, T. | Peleg Hasson, S. | Saad, A. | +5

19

Preimplantation genetic testing for BRCA gene mutation carriers : a cost effectiveness analysis

enthalten in: Reproductive biology and endocrinology : RB&E | 2021

von Michaan, N. | Leshno, M. | Cohen, Y. | +4

20

Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis

enthalten in: Reproductive biology and endocrinology | 2021

von Michaan, N. | Leshno, M. | Cohen, Y. | +4